• to decrease the risk of critical cardiovascular (coronary heart and blood vessel) problems in adults with style two diabetes and heart problemsThis led Novo Nordisk to carry out further investigation into higher dosages of semaglutide especially for weight administration.To find out more about making use of Rybelsus or copyright for weight loss